CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 128992-129157 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"A phase II study in 307 ambulatory elderly adults, aged 60-80 years, was undertaken to determine the dose regimen of BBG2Na to be used for phase III efficacy trials.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T790","span":{"begin":0,"end":165},"obj":"Sentence"},{"id":"T85887","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T790","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T85887","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T195","span":{"begin":0,"end":165},"obj":"Sentence"}],"attributes":[{"subj":"T195","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T695","span":{"begin":69,"end":72},"obj":"Disease"}],"attributes":[{"id":"A695","pred":"mondo_id","subj":"T695","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T695","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#bf93ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93eca5"},{"id":"CORD-19-PD-MONDO","color":"#ec939b"}]}]}}